Marine bacteria as source of antimicrobial compounds

Area of Science:

• Marine microbiology
• Natural product chemistry
• Drug discovery

Background:

• The marine environment harbors vast, underexplored biodiversity with potential for novel bioactive molecules.
• Marine bacteria are a significant source of antimicrobial compounds, crucial for developing new therapeutics.
• Understanding the sources and types of antimicrobial substances from marine bacteria is vital for pharmaceutical research.

Purpose of the Study:

• To review the current state of knowledge on antimicrobial molecules derived from marine bacteria.
• To identify the main bacterial phyla and sources involved in producing these bioactive compounds.
• To highlight trends and key discoveries in marine bacterial antimicrobial research over the past two decades.

Main Methods:

• Literature review summarizing research on marine bacteria and their antimicrobial products.
• Analysis of studies focusing on bacterial phyla, sources, and identified chemical structures.
• Comparative assessment of research trends concerning Firmicutes and Actinobacteria.

Main Results:

• The Firmicutes phylum, especially the Bacillus genus, has historically been the most studied for antimicrobial production.
• Difficulty in cultivating marine Actinobacteria contributed to their initial underrepresentation compared to terrestrial counterparts.
• Recent years show an increasing focus on Actinobacteria, with diverse chemical structures like fijimicins, lynamicins, and macrolactins being identified.

Conclusions:

• Marine bacteria, particularly Firmicutes and increasingly Actinobacteria, are crucial sources of diverse antimicrobial molecules.
• Continued exploration of marine Actinobacteria is promising for discovering novel chemical entities with therapeutic potential.
• The identified compounds like fijimicins, lynamicins, and macrolactins represent significant advancements in antimicrobial drug discovery.